

Publisher: John Wiley & Sons Inc
E-ISSN: 1472-8206|30|5|450-458
ISSN: 0767-3981
Source: Fundamental & Clinical Pharmacology, Vol.30, Iss.5, 2016-10, pp. : 450-458
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Cells Tissues Organs, Vol. 189, Iss. 1-4, 2008-08 ,pp. :






Bisphosphonate-associated risk of jaw osteonecrosis?
Reactions Weekly, Vol. 1, Iss. 1131, 2006-01 ,pp. :


Reduced bisphosphonate schedule may decrease jaw osteonecrosis risk
Reactions Weekly, Vol. 1, Iss. 1135, 2007-01 ,pp. :